HC Wainwright Reiterates Buy Rating on Connect Biopharma, Sets $7 Target
HC Wainwright reiterated its Buy rating and $7.00 price target on Connect Biopharma. The target implies 730.9% upside from the stock’s Oct. 27 close of $0.84.
Story updates
11:49:55 AM UTC
SquawkNews
Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.